|
| Analyst
Scorecard | | Analyst: | Samimy, Annabel | EPS
Est. Accuracy: | 
| | Broker: | Thomas Weisel Partners | Recommendation
Performance: | Not Avl.
|
|
What is this?
This scorecard presents a summary of StarMine ratings
for this analyst.
Ratings are displayed when analysts score highly based
on the accuracy of
their earnings estimates or the returns of their stock
recommendations. Stocks
which appear on this scorecard are limited to those
covered by the analyst for
a significant period of time. Learn
More
|
| |
Industry Coverage
| | |
Industry
|
EPS Est. Accuracy
|
Industry Excess Return
|
Industry Return
| | | |
Biotechnology
|
| Not Avl.
| Not Avl.
| | | |
| |
EPS Estimate Accuracy
| | |
Symbol
|
Company Name
|
EPS Est. Accuracy
|
No. Analysts
| | | |
CEPH
|
Cephalon Inc
|
|
22
| | | | |
FRX
|
Forest Laboratories Inc
| 
|
23
| | | | |
SNTS
|
Santarus Inc
|
|
4
| | | |
| Other Stocks Covered
| |
Allergan Inc (AGN), Auxilium Pharmaceuticals Inc (AUXL), Corcept Therapeutics Inc (CORT), Endo Pharmaceuticals (ENDP), Ista Pharmaceuticals Inc (ISTA), Medicis Pharmaceutical Corp (MRX), Obagi Medical Products Inc (OMPI)
|
| | |
|
|
|